Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Reducing expenses is essential for better budgeting. Explore effective strategies to cut costs and enhance your savings potential.
20,180 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A CFO selling NuScale stock can spark questions about the company’s outlook. This guide breaks down what the move mig...
Nvidia surged into the spotlight as a long-term wealth engine for many investors. This guide asks the hard question: ...
Samara unveils Locale by Samara, its first single-family model in California, aiming to ease housing shortages by bui...
When SK Hynix opened its largest-ever share sale, demand overwhelmed the supply, and investors wanted billion more. T...
Intuitive Surgical stock has faced a challenging 2026, dipping from highs and patchy returns as investors weigh multi...
Lawmakers are rushing to end the $24,480 earnings limit that reduces Social Security benefits for retirees who keep w...
A nationwide surge in AI use for homework collides with a growing gap in school policies. This report tracks the numb...
A Sea Limited executive sold $4.4 million in stock but remains one of the company’s biggest stakeholders. This piece ...
Bank of America named two new leaders to oversee digital assets and AI transformation, signaling a strategic push to ...
A top financial executive recently disclosed a share sale at Robinhood. This article breaks down what the move means,...
A late-July meeting to craft an ethics clause for the President’s crypto holdings stalled, keeping Clarity Act negoti...